Biogen Inc

NASDAQ:BIIB   3:59:59 PM EDT
271.11
+1.17 (+0.43%)
4:26:34 PM EDT: $271.23 +0.12 (+0.04%)
Products

FDA Approves Samsung Bioepis And Biogen’s BYOOVIZ, LUCENTIS Biosimilar

Published: 09/20/2021 11:59 GMT
Biogen Inc (BIIB) - FDA Approves Samsung Bioepis and Biogen’s Byooviz™ (sb11), Lucentis® Biosimilar (ranibizumab-nuna).